|
ZCCHC8 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.62447832963153E-12 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.62447832963153E-12 |
| Normal-vs-Stage2 |
1.70369999996645E-06 |
| Normal-vs-Stage3 |
2.35620412070148E-11 |
| Normal-vs-Stage4 |
9.07363073565648E-12 |
| Stage1-vs-Stage2 |
2.465600E-01 |
| Stage1-vs-Stage3 |
1.460400E-01 |
| Stage1-vs-Stage4 |
5.039400E-01 |
| Stage2-vs-Stage3 |
9.389600E-01 |
| Stage2-vs-Stage4 |
5.933800E-01 |
| Stage3-vs-Stage4 |
5.730600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
<1E-12 |
| Normal-vs-AfricanAmerican |
1.78630000013946E-07 |
| Normal-vs-Asian |
4.377800E-03 |
| Caucasian-vs-AfricanAmerican |
8.381000E-01 |
| Caucasian-vs-Asian |
7.142300E-02 |
| AfricanAmerican-vs-Asian |
9.212200E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
<1E-12 |
| Normal-vs-Female |
1.11022302462516E-16 |
| Male-vs-Female |
8.721200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.957490E-03 |
| Normal-vs-Age(41-60Yrs) |
<1E-12 |
| Normal-vs-Age(61-80Yrs) |
1.62458935193399E-12 |
| Normal-vs-Age(81-100Yrs) |
6.936900E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.306000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.514200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.701400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.895160E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.604200E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.912580E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
2.57029952877019E-10 |
| Normal-vs-Grade 2 |
1.62447832963153E-12 |
| Normal-vs-Grade 3 |
1.626032641866E-12 |
| Normal-vs-Grade 4 |
2.39619999999885E-05 |
| Grade 1-vs-Grade 2 |
4.291400E-01 |
| Grade 1-vs-Grade 3 |
5.711500E-02 |
| Grade 1-vs-Grade 4 |
1.319980E-02 |
| Grade 2-vs-Grade 3 |
9.036100E-03 |
| Grade 2-vs-Grade 4 |
4.788800E-04 |
| Grade 3-vs-Grade 4 |
5.548500E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.62436730732907E-12 |
| Normal-vs-ccB subtype |
2.32849994841189E-09 |
| ccA subtype-vs-ccB subtype |
1.33040000016571E-07 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.66133814775094E-16 |
| Normal-vs-N1 |
3.696200E-02 |
| N0-vs-N1 |
3.867600E-01 |
|
|
